You just read:

Cellecta, Inc. Receives Phase II NIH SBIR Grant to Develop Advanced CRISPR/Cas9 Genome-Wide sgRNA Library Screening Platform

News provided by

Cellecta, Inc.

26 Jan, 2017, 08:40 ET